Blog
2 Dividend Kings That Are Trouncing the Market This Year
The S&P 500 has rebounded from earlier-year losses and is back to hitting new highs. Conventional wisdom is that growth stocks drive the market higher in good times, and safe stocks outperform when
Stock Market Today, May 13: Eos Energy Initially Spikes Then Gives Back Returns After Q1 Earnings Beat
Eos Energy Enterprises (NASDAQ:EOSE), a zinc-based energy storage provider, closed Wednesday at $8.28, up 2.22%. The stock initially moved 20% higher after a Q1 earnings beat, reaffirmed 2026
Denver PWM Trims Its Treasury ETF Stake -- Selling $2.6 Million Worth of IBTG
According to a recent SEC filing, Denver PWM, LLC sold 112,199 shares of the iShares iBonds Dec 2026 Term Treasury ETF (NASDAQ:IBTG) during the first quarter of 2026. Based on the quarter’s average
One Overlooked Financial Improvement That Makes CoreWeave Stock an Increasingly Attractive Buy
CoreWeave (NASDAQ: CRWV) stock plunged following the release of its first-quarter 2026 earnings report. Although investors likely dismissed its net losses, its falling operating margins, its massive
Can Uber Make an “Everything” App?
In this episode of Motley Fool Hidden Gems Investing, Motley Fool contributors Travis Hoium, Lou Whiteman, and Rachel Warren discuss:
To catch full episodes of all The Motley Fool's free podcasts
10 Years Later: 5 Winners in a Thinking World
In this episode of Motley Fool Rule Breaker Investing, Motley Fool co-founder David Gardner welcomes Motley Fool analyst Tim Beyers, and together they go back exactly 10 years—to the week—to revisit
Cerebras IPO: Here's What a $5,000 Investment Could Look Like in 5 Years
The artificial intelligence (AI) infrastructure race has produced no shortage of headline-grabbing companies. With its initial public offering (IPO) set for May 14, Cerebras may be the most closely
Why Plug Power Stock Skyrocketed Today
Plug Power (NASDAQ: PLUG) stock closed out Wednesday's trading with a big gain. The company's share price ended the daily session up 11.2% in the session and had been up as much as 15.4% earlier in
Why This Biotech Fund Added $7 Million to an Oncology Stock Up 120%
Avidity Partners Management disclosed a buy of 259,700 shares of Enliven Therapeutics (NASDAQ:ELVN) in its May 13, 2026, SEC filing, an estimated $7.19 million transaction based on quarterly average
Stellantis Is Finally About to Make the Critical Decision It Needs to Move Forward
Investors following a possible Stellantis (NYSE: STLA) turnaround likely know the automaker's plate is full. It has to transition into new leadership, repair relations with its dealership network
Abeona (ABEO) Q1 2026 Earnings Transcript
Image source: The Motley Fool.
Wednesday, May 13, 2026 at 8:30 a.m. ET
Need a quote from a Motley Fool analyst? Email [email protected]
Source Fool.com
Altimmune (ALT) Q1 2026 Earnings Transcript
Image source: The Motley Fool.
Wednesday, May 13, 2026 at 8:30 a.m. ET
Need a quote from a Motley Fool analyst? Email [email protected]
Source Fool.com
This Nuclear Stock Controls the Only Large Reactor Manufacturing Facility in North America, and Its Backlog Grew 50% in 2025. Time to Buy?
BWX Technologies (NYSE: BWXT), an American engineering and manufacturing company that serves the defense and nuclear energy markets, claims to be the "only large, commercial nuclear equipment
Better Buy: Taiwan Semiconductor vs. Micron Stock
In the chip manufacturing world, there are two primary types of chips made: memory and logic chips. Each serves a different purpose in a computer, and each is important.
In the logic chip world
Why Lucid Stock Skyrocketed Today
Lucid (NASDAQ: LCID) stock posted big gains in Wednesday's trading. The company's share price rose 6.3% in a session that saw the S&P 500 gain 0.5% and the Nasdaq Composite rise 1.2%. Lucid stock
Why Paysign Plunged Today
The small-cap payment card processor Paysign (NASDAQ: PAYS) fell on Wednesday, dropping as much as 27.7%, before recovering to a 12.3% decline on the day.
Paysign reported first-quarter earnings
Why This Biotech Fund Opened a $9 Million Position in a Newly Public Cancer Company
On May 13, 2026, Avidity Partners Management disclosed a new position in Aktis Oncology (NASDAQ:AKTS), acquiring 468,566 shares in the first quarter. The estimated transaction value was $9.10
The AI Supercycle Has Moved Beyond Memory Chips. This Supercharged Tech Stock Has Gained 169% in 2026 and Is Riding the Next Wave
There is no denying that we are in the midst of an artificial intelligence (AI) supercycle, a prolonged period of strong demand for products and/or services that outstrips supply.
The AI supercycle
EchoStar (SATS) Q1 2025 Earnings Transcript
Image source: The Motley Fool.
Friday, May 9, 2025 at 11:00 a.m. ET
Need a quote from a Motley Fool analyst? Email [email protected]
Source Fool.com
Nio Swapped 1 Million EV Batteries in a Week While Tesla Owners Waited 30 Minutes to Charge. Is NIO Stock a Buy?
Nio (NYSE: NIO), a major electric vehicle producer in China, differentiates itself from other EV makers through its swappable batteries. Its drivers can quickly swap out batteries at its
Why This Biotech Fund Increased Its Oruka Therapeutics Stake Amid a Staggering 500% Rally
Avidity Partners Management disclosed a buy of 100,000 shares of Oruka Therapeutics (NASDAQ:ORKA) in a May 13, 2026, SEC filing, with an estimated transaction value of $3.48 million based on
The Best Growth Stock to Buy After This Year's Market Pullback
Flutter Entertainment (NYSE: FLUT), the parent company of FanDuel online sports betting, has been on a losing streak so far in 2026. Flutter's stock price has plummeted 56% year to date to a nearly
Why Oklo Stock Is Sinking Today
Oklo (NYSE: OKLO) stock is moving lower in Wednesday's trading. The company's share price was down 5.3% as of 3:30 p.m. ET. Meanwhile, the S&P 500 was up 0.7%, and the Nasdaq Composite was up 1.2%.
Stellantis Has Slipped Off Investors' Radar. Does a Huge Beat Say Think Again?
Stellantis (NYSE: STLA) has a lot on its plate right now. The automaker is undergoing a new leadership transition, making tough decisions about overcapacity in North America and Europe, reversing